JP

Jayaprakash Polei

Active Director Director DIN 10811819
DIN 10811819 First appointment Oct 2024 Primary industry Research & Development
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Oct 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Jayaprakash Polei

Data last updated:

Jayaprakash Polei is a Director at Tarinee Pharmaceuticals Private Limited (since 2024). The company operates in Research & Development.

DIN 10811819
Primary Designation Director
Industry Research & Development
First Appointment 17 Oct 2024
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director17 Oct 20242024Active

Board colleagues of Jayaprakash Polei

NameDINCompanyDesignation
Ranusmita Khuntia10811820Tarinee Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Tarinee Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Jayaprakash Polei

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Jayaprakash Polei

Jayaprakash Polei currently holds 1 directorship: Tarinee Pharmaceuticals Private Limited (Director, since 17 Oct 2024).

Jayaprakash Polei was first appointed on 17 Oct 2024 as Director at Tarinee Pharmaceuticals Private Limited.

The current boards of Jayaprakash Polei's companies include Ranusmita Khuntia (Tarinee Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available